← Leaderboards
John S. Lollar
Emory University
$19,901,192
Attributed
$21,345,381
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$41,597,486 · 17
By mechanism
U54$34,345,665 · 11
R01$4,937,912 · 2
R44$1,483,531 · 1
R43$682,752 · 2
T32$147,626 · 1
Top collaborators
- Gabriela Denning4 shared
- Christopher Bradley Doering4 shared
Most similar at Emory University
Same institution · by research overlap
- Daniel J Brat$12,411,183
- Shannon L. Meeks$9,405,167
- Mark Mariusz Bouzyk$828,482
- Frank Schneider$169,563
Others in their field
Top investigators on “Hemophilia A”
- Carol H Miao · Seattle Children'S Hospital$27,105,989
- Mark A Kay · Stanford University$24,062,703
- Roland W. Herzog · Indiana University Indianapolis$22,911,482
- Timothy Charles Nichols · University Of North Carolina Chapel Hill$19,506,050
- Mortimer Poncz · University Of Pennsylvania$14,969,626
- Paul K Whelton · Tulane University Of Louisiana$13,863,648
Research focus
Hemophilia AVariantBiologicalInhibitor/AntagonistHemorrhageAntibodiesEpitopesStructureMolecularBaseProteinsImmune ResponsePlasmaHemostatic FunctionProgramsUniversitiesComplicationMapsInfusion ProceduresResearch PersonnelDesignResponseLaboratoriesImmunogenicity
Grant awards (74)
Unraveling the immune response to factor VIII$1,613,298
U54 · FY2022 · HL · contact PI
The Structural Basis for the Immune Recognition of Factor VIII$381,589
U54 · FY2022 · HL · contact PI
Unraveling the immune response to factor VIII$1,618,258
U54 · FY2021 · HL · contact PI
The Structural Basis for the Immune Recognition of Factor VIII$386,549
U54 · FY2021 · HL · contact PI
Unraveling the immune response to factor VIII$1,621,013
U54 · FY2020 · HL · contact PI
The Structural Basis for the Immune Recognition of Factor VIII$389,304
U54 · FY2020 · HL · contact PI
Unraveling the immune response to factor VIII$1,623,679
U54 · FY2019 · HL · contact PI
The Structural Basis for the Immune Recognition of Factor VIII$391,970
U54 · FY2019 · HL · contact PI
Unraveling the immune response to factor VIII$1,640,259
U54 · FY2018 · HL · contact PI
The Structural Basis for the Immune Recognition of Factor VIII$408,550
U54 · FY2018 · HL · contact PI
Biological Variation in Hemophilia$2,434,741
U54 · FY2016 · HL · contact PI
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia$534,020
U54 · FY2016 · HL · contact PI
Molecular Heterogeneity in FVIII Inhibitor Patients$403,288
U54 · FY2016 · HL · contact PI
The Immune Response to Factor Vlll$398,992
U54 · FY2016 · HL · contact PI
Eradication of FVIII Inhibitors using Gene-Based Therapy$374,319
U54 · FY2016 · HL · contact PI
Animal Core$280,721
U54 · FY2016 · HL · contact PI
Biorepository Core$196,008
U54 · FY2016 · HL · contact PI
Administrative Core$130,017
U54 · FY2016 · HL · contact PI
Translational Research Skills$117,376
U54 · FY2016 · HL · contact PI
Biological Variation in Hemophilia$2,426,239
U54 · FY2015 · HL · contact PI
Bioengineered Recombinant FVIII$673,613
R44 · FY2015 · HL
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia$557,301
U54 · FY2015 · HL · contact PI
Molecular Heterogeneity in FVIII Inhibitor Patients$398,669
U54 · FY2015 · HL · contact PI
The Immune Response to Factor Vlll$394,373
U54 · FY2015 · HL · contact PI
Eradication of FVIII Inhibitors using Gene-Based Therapy$369,700
U54 · FY2015 · HL · contact PI
Animal Core$276,568
U54 · FY2015 · HL · contact PI
Biorepository Core$191,390
U54 · FY2015 · HL · contact PI
Administrative Core$125,398
U54 · FY2015 · HL · contact PI
Translational Research Skills$112,840
U54 · FY2015 · HL · contact PI
Biological Variation in Hemophilia$2,434,893
U54 · FY2014 · HL · contact PI
Bioengineered Recombinant FVIII$809,918
R44 · FY2014 · HL
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia$534,020
U54 · FY2014 · HL · contact PI
Molecular Heterogeneity in FVIII Inhibitor Patients$403,288
U54 · FY2014 · HL · contact PI
The Immune Response to Factor Vlll$398,991
U54 · FY2014 · HL · contact PI
Eradication of FVIII Inhibitors using Gene-Based Therapy$374,319
U54 · FY2014 · HL · contact PI
Animal Core$280,721
U54 · FY2014 · HL · contact PI
Biorepository Core$196,008
U54 · FY2014 · HL · contact PI
Administrative Core$130,017
U54 · FY2014 · HL · contact PI
Translational Research Skills$117,529
U54 · FY2014 · HL · contact PI
Biological Variation in Hemophilia$2,316,439
U54 · FY2013 · HL · contact PI
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia$496,434
U54 · FY2013 · HL · contact PI
Manufacturing Process Development for Bioengineered FVIII$386,432
R43 · FY2013 · HL
The Immune Response to Factor Vlll$374,911
U54 · FY2013 · HL · contact PI
Molecular Heterogeneity in FVIII Inhibitor Patients$361,701
U54 · FY2013 · HL · contact PI
Eradication of FVIII Inhibitors using Gene-Based Therapy$352,704
U54 · FY2013 · HL · contact PI
Animal Core$268,464
U54 · FY2013 · HL · contact PI
Biorepository Core$207,747
U54 · FY2013 · HL · contact PI
Administrative Core$132,831
U54 · FY2013 · HL · contact PI
Translational Research Skills$121,647
U54 · FY2013 · HL · contact PI
Biological Variation in Hemophilia$2,523,286
U54 · FY2012 · HL · contact PI
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia$315,411
U54 · FY2012 · HL · contact PI
Translational Research Skills$315,411
U54 · FY2012 · HL · contact PI
Administrative Core$315,411
U54 · FY2012 · HL · contact PI
Molecular Heterogeneity in FVIII Inhibitor Patients$315,411
U54 · FY2012 · HL · contact PI
Eradication of FVIII Inhibitors using Gene-Based Therapy$315,411
U54 · FY2012 · HL · contact PI
The Immune Response to Factor Vlll$315,411
U54 · FY2012 · HL · contact PI
Biorepository Core$315,410
U54 · FY2012 · HL · contact PI
Animal Core$315,410
U54 · FY2012 · HL · contact PI
Development of a novel production platform for complex recombinant biotherapeutic$296,320
R43 · FY2012 · HL
The Immune Response to Factor VIII$483,647
R01 · FY2010 · HL · contact PI
Structure and Function of the Factor VIII - von Willebrand Factor Complex$356,675
R01 · FY2010 · HL · contact PI
The Immune Response to Factor VIII$483,647
R01 · FY2009 · HL · contact PI
Structure and Function of the Factor VIII - von Willebrand Factor Complex$386,772
R01 · FY2009 · HL · contact PI
The Immune Response to Factor VIII$362,679
R01 · FY2008 · HL · contact PI
The Immune Response to Factor VIII$362,679
R01 · FY2007 · HL · contact PI
The Immune Response to Factor VIII$373,511
R01 · FY2006 · HL · contact PI
The Immune Response to Factor VIII$382,500
R01 · FY2005 · HL
Structure and Function of the Factor VIII-vWf Complex$304,000
R01 · FY2005 · HL
Structure and Function of the Factor VIII-vWf Complex$304,000
R01 · FY2004 · HL
Structure and Function of the Factor VIII-vWf Complex$304,000
R01 · FY2003 · HL
Structure and Function of the Factor VIII-vWf Complex$304,000
R01 · FY2002 · HL
STRUCTURE/FUNCTION OF THE FACTOR VIII VWF COMPLEX$267,058
R01 · FY2001 · HL
STRUCTURE/FUNCTION OF THE FACTOR VIII VWF COMPLEX$262,744
R01 · FY2000 · HL
RESEARCH TRAINING IN ACADEMIC HEMATOLOGY$147,626
T32 · FY2000 · HL